LATEST PRESS RELEASES


Notice: Function WP_Object_Cache::add was called incorrectly. Cache key must not be an empty string. Please see Debugging in WordPress for more information. (This message was added in version 6.1.0.) in /var/www/vhosts/shroominvestor.com/httpdocs/web/wp/wp-includes/functions.php on line 6031

Notice: Function WP_Object_Cache::add was called incorrectly. Cache key must not be an empty string. Please see Debugging in WordPress for more information. (This message was added in version 6.1.0.) in /var/www/vhosts/shroominvestor.com/httpdocs/web/wp/wp-includes/functions.php on line 6031
1166 views8 min read

Numinus Announces Compassionate Access Trial of Psilocybin-Assisted Psychotherapy for Substance Use Disorders

Numinus Wellness
Open-label clinical trial will evaluate and refine best practices for the delivery of psilocybin-assisted psychotherapy for participants with tobacco, stimulant, alcohol, and/or opioid disorders VANCOUVER, BC, Nov. 18, 2020 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a company creating an ecosystem of solutions centred on the resear... Read More...
803 views5 min read

PharmaTher Enters Into Research Collaboration with Revive Therapeutics for Psilocybin and panaceAI™ Psychedelic Discovery AI Platform

Revive Therapeutics
TORONTO, Nov. 18, 2020 -- PharmaTher Inc., a wholly-owned subsidiary of Newscope Capital Corporation (“PharmaTher”) (CSE: PHRM) and a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals, is pleased to announce it has entered into an exclusive research collaboration agreement with Revive T... Read More...
362 views4 min read

Revive Therapeutics Announces Research Collaboration with PharmaTher for Development of Psilocybin in Cancer and Discovery of Novel Uses of Psychedelics

Revive Therapeutics
TORONTO, Nov. 18, 2020 -- Revive Therapeutics Ltd. (“Revive”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce it has entered into an exclusive research collaboration agreement with PharmaTher Inc., a wholly-owned ... Read More...
4 views4 min read

Red Light Holland Engages RadixMotion to Develop iMicrodose Digital Care Program Using Latest Immersive Technology

Red Light Holland
Toronto, Ontario--(Newsfile Corp. - November 17, 2020) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) ("Red Light Holland" or the "Company") is pleased to announce that via its Scarlette Lillie Science and Innovation division, it has engaged RadixMotion Inc. ("RadixMotion"), an immersive technology company based in the State of Delaware... Read More...
601 views8 min read

Mydecine Innovations Group Offers Management and Clinical Trials Update

Mydecine Innovations Group
Dr. Rakesh Jetly Appointed Chief Medical OfficerCompany Announces International Expansion of Clinical Trial Sites for Phase 2A Study into Psychedelic Treatments for PTSD in VeteransVANCOUVER, British Columbia, Nov. 17, 2020 -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (“Mydecine” or the “Company’), an emerging biopharma and life... Read More...
1195 views6 min read

Field Trip Health Ltd. Announces Expansion to The Netherlands and Launch of Proprietary Truffle Program

The Field Trip Health Center in Amsterdam Will Focus on Providing Psychedelic Preparation and Integration Therapy with Legal Truffles Containing PsilocybinAMSTERDAM, Nov. 17, 2020 -- Field Trip Health Ltd. (CSE: FTRP, OTCBB: FTRPF) ("Field Trip"), a global leader in the development and delivery of technology-enabled psychedelic therapies,... Read More...
80 views4 min read

Better Plant Launches New Jusu Ecommerce Site

Better Plant Sciences
Vancouver, British Columbia--(Newsfile Corp. - November 17, 2020) - Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) ("Better Plant") or (the "Company") is pleased to launch the new Jusu eCommerce site at getjusu.com and the Jusu product rebrand following the Company's recent acquisition of Jusu, which produces a line of p... Read More...
1 views2 min read

Silo Pharma, Inc. Expands Scientific Advisory Board with the Appointment of Dr. Joshua Woolley of University of California, San Francisco

Silo Pharma
NEW YORK , Nov. 16, 2020 -- Silo Pharma, Inc. (OTCQB: SILO) today announced that its Board of Directors has named scientific research investigator Dr. Joshua Woolley, M.D. / Ph.D. to its newly formed Scientific Advisory Board.Dr. Joshua Woolley M.D. / Ph.D. is an Associate Professor in Residence, Department of Psychiatry at the University... Read More...
955 views7 min read

Lobe Sciences Commences Trading Under New Name and Announces Rebranding and Corporate Update

Lobe Sciences
Lobe Sciences unveils new corporate name and logo as part of an extensive rebranding initiative, reflective of the Company's focus on psychedelic medicinesVancouver, British Columbia--(Newsfile Corp. - November 16, 2020) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce that today it will ... Read More...
197 views7 min read

MindMed Receives Approval of Protocol Design to Evaluate Microdoses of LSD For Adult ADHD In Phase 2a Clinical Trial from Swiss and Dutch Health Authorities

Mind Medicine (MindMed)
Project Lucy Submits Pre-IND Briefing Package to the FDA; Agrees Q1 Interim Analysis of Swiss Phase 2a Trial of LSD Assisted Therapy for Anxiety DisordersNEW YORK and BASEL, Switzerland, Nov. 16, 2020 -- MindMed (NEO: MMED), (OTCQB: MMEDF), (DE: MMQ), a leading psychedelic medicine biotech company, has received a positive response on its ... Read More...
1410 views7 min read

Empower Clinics Kai Medical Lab Receives Record Order in Excess of $1,000,000 for COVID-19 Tests from Film and Television Production

Empower Clinics
Kai Medical Laboratory, a state-of-the-art diagnostics laboratory in Dallas, was acquired by Empower Clinics on October 6, 2020 to further advance the Company's COVID-19 national testing programs for enterprise clients, including movie and television studios, businesses and collegesVANCOUVER BC / ACCESSWIRE / November 16, 2020 / EMPOWER C... Read More...
734 views11 min read

Silo Wellness Announces the First-of-Its-Kind U.S.-Legal Psychedelic Wellness Nature Retreat in Oregon

Yukoterre Resources
Psychedelic Retreat Offering Follows Passing of Oregon’s Measure 109SPRINGFIELD, Ore., Nov. 13, 2020 -- Oregon’s Silo Wellness (“Silo”), an early mover in the psychedelic mushroom space is pleased to announce that it is organizing a ketamine-assisted wellness retreat in Oregon under the care of Dr. Matthew Hicks, ND, MS. This will add to ... Read More...
1330 views6 min read

Empower Clinics Kai Medical Laboratory Achieves Record Testing Volume Month in October and Signs Numerous New Contracts

Empower Clinics
Kai Medical Laboratory, a state-of-the-art diagnostics laboratory in Dallas, was acquired by Empower Clinics on October 6, 2020 to further advance the Company's COVID-19 national testing programs for enterprise clients, including movie and television studios, businesses and collegesVANCOUVER, BC / ACCESSWIRE / November 13, 2020 / EMPOWER ... Read More...
522 views3 min read

Maibec® is Acquiring Stave Lake Cedar Mills Prefinishing Facility, British Colombia, and Stave Lake Brands®

Mind Cure Health
MAPLE RIDGE, BC and LÉVIS, QC, Nov. 12, 2020 /CNW Telbec/ - Maibec inc and Waldun Forest Ltd announced today a joint agreement for Maibec's acquisition of Stave Lake Cedar Mills prefinishing facility located in Dewdney, British Columbia as well as the assets and brand rights for Stave Lake Cedar Shingles, value added Western Red Cedar and... Read More...
858 views30 min read

Dillard’s, Inc. Reports Third Quarter Results

Pharmadrug
Dillard’s, Inc. (NYSE: DDS) (the "Company" or "Dillard’s") announced operating results for the 13 and 39 weeks ended October 31, 2020. This release contains certain forward-looking statements. Please refer to the Company’s cautionary statements included below under "Forward-Looking Information." In particular, these results include certai... Read More...
M & A1 views0 min read

Mukesh (Steve) Singh Announces Filing of Early Warning Report Related to the Acquisition of Common Shares of Canbud Distribution Corporation

Canbud Distribution
Toronto, Ontario--(Newsfile Corp. - November 12, 2020) - Mukesh (Steve) Singh (the "Acquiror") announces that he has filed an early warning report (the "Report") announcing that, on November 11, 2020, he acquired 2,865,000 common shares (the "Acquired Shares") of Canbud Distribution Corporation (CSE: CBDX) (the "Issuer"). The Acquired Sha... Read More...
M & A35 views4 min read

Agritek Holdings Inc. Announces Executed Asset Purchase Agreement For Acquisition Of Full Spectrum Biosciences By Canada Based Primo Nutraceuticals Inc. Trading On CSE and OTC Exchanges

Primo Nutraceuticals
LOS ANGELES, CA / ACCESSWIRE / November 12, 2020 / Agritek Holdings, Inc. (OTC PINK:AGTK) (www.AgritekHoldings.com), a fully integrated, active real estate investor and its wholly owned subsidiary Full Spectrum Biosciences Inc. an IP, formulation and white label provider for popular hemp brands RehabRx and Hemp Pops among others, today an... Read More...
LOIM & A55 views8 min read

Primo Nutraceuticals Inc. Enters intoa Binding LOI to acquire 100% of the Assets of Full Spectrum Biosciences Inc.

Primo Nutraceuticals
VANCOUVER, British Columbia, Nov. 12, 2020 -- PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF ) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (" PRIMO ") is pleased to announce that it has signed a binding letter of intent (“LOI”) with Full Spectrum Biosciences Inc.(“FSB”),a Colorado company.FSB is an intellectual property (“IP”), formula... Read More...
81 views2 min read

GreenStar Biosciences Announces Name Change

Lobe Sciences
Vancouver, British Columbia--(Newsfile Corp. - November 11, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company") announces today it will be seeking approval of the Canadian Securities Exchange (the "CSE") to change its name from GreenStar Biosciences Corp. to Lobe Sciences Ltd. and change its CS... Read More...
128 views0 min read

Dillard’s, Inc. to Report Third Quarter Results

Pharmadrug
Dillard’s, Inc. (NYSE: DDS) will announce results for the 13 and 39 weeks ended October 31, 2020 tomorrow after the close of the New York Stock Exchange.View source version on businesswire.com: https://www.businesswire.com/news/home/20201111005753/en/ContactsJulie J. GuymonDirector of Investor Relations(501) 376-5965julie.guymon@dillards.... Read More...
M & A138 views4 min read

Nova Mentis Life Science Acquisition Target, Pilz Bioscience Corp, Provides Corporate Update

Novamind
VANCOUVER, BC, Nov. 11, 2020 - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) ("NOVA") is pleased to announce that its pending acquisition target, Pilz Bioscience Corp. ("Pilz"), has provided a corporate update.Dr. Marvin S. Hausman MD, Chairman and Chief Scientific Officer of Pilz commented: "We are very pleased wi... Read More...
388 views3 min read

Pure Extracts Technologies Corp. Welcomes Dwight Duncan to its Board of Directors

Pure Extracts Technologies
VANCOUVER, British Columbia, Nov. 10, 2020 -- Pure Extracts Technologies Corp. (“Pure Extracts”) (CSE: PULL), a plant-based extraction company focused on cannabis, hemp, and functional mushroom sectors, is pleased to welcome its newest Board member, Dwight Duncan.“We are pleased to welcome Dwight Duncan to the Board of Pure Extracts,” sai... Read More...





Make smarter investment strategies
with in-depth news reports

Join our subscribers!